AACR Congratulates Fellows, Board Members, and Members Elected to the National Academy of Medicine

PHILADELPHIA – The American Association for Cancer Research (AACR) extends its warmest congratulations to the 15 AACR members who have been elected to the National Academy of Medicine (NAM) as part of its 2023 class. This year’s class includes five members of the AACR Board of Directors, three of whom are also Fellows of the AACR Academy.

The following members of the AACR Board of Directors were elected to the NAM:

• John D. Carpten, PhD, FAACR, City of Hope
• Luis A. Diaz Jr., MD, FAACR, Memorial Sloan Kettering Cancer Center
• Lisa A. Newman, MD, MPH, NewYork-Presbyterian/Weill Cornell Medical Center and Weill Cornell Medicine
• Robert H. Vonderheide, MD, DPhil, Abramson Cancer Center, University of Pennsylvania
• Jedd Wolchok, MD, PhD, FAACR, Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine

Other AACR members elected to the NAM include:

• Daniel G. Anderson, PhD, Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology
• Bradley Bernstein, MD, PhD, Dana-Farber Cancer Institute
• Timothy A. Chan, MD, PhD, Cleveland Clinic and Case Western Reserve University
• Kojo S.J. Elenitoba-Johnson, MD, Memorial Sloan Kettering Cancer Center
• Darrell J. Irvine, PhD, Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology
• Steven D. Leach, MD, Dartmouth Cancer Center, Dartmouth Geisel School of Medicine
• Miriam Merad, MD, PhD, Icahn School of Medicine at Mount Sinai
• Brent R. Stockwell, PhD, Columbia University Irving Medical Center
• Jennifer A. Wargo, MD, MMSc, The University of Texas MD Anderson Cancer Center
• Yi Zhang, PhD, Boston Children’s Hospital

“We are very proud of AACR’s leaders and members whose tremendous scientific accomplishments have been recognized with their election to the National Academy of Medicine this year,” said Margaret Foti, PhD, MD (hc), chief executive officer of AACR. “The dedicated efforts of these expert and distinguished scientists have significantly enhanced our understanding of the complexities of cancer and contributed to lifesaving advances in cancer biology, prevention, detection, diagnosis, and treatment. We extend our profound congratulations to them on this richly deserved national honor.”